0 Evaluaciones
ID

14545

Descripción

Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00766090

Link

https://clinicaltrials.gov/show/NCT00766090

Palabras clave

Versiones (1)
  1. 20/4/16 20/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

20 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility Asthma NCT00766090

    Inglés

    Eligibility Asthma NCT00766090

    1 formularios  
    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00766090
    Criteria
    Descripción

    Criteria

    clinical diagnosis of asthma
    Descripción

    asthma

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0004096
    reversibility ≥ 12% and ≥200mls reversibility of fev1 within approximately 30-minutes following 2 to 4 puffs of albuterol
    Descripción

    fev1 reversibility after albuterol

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0748133
    UMLS CUI [1,2]
    C0449261
    UMLS CUI [2]
    C0001927
    fev1 between 40-85% predicted
    Descripción

    fev1

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0748133
    currently on short acting beta2 agonist therapy
    Descripción

    short-acting beta-2 agonist

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1373132
    key exclusion criteria:
    Descripción

    exclusion criteria

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0680251
    history of life threatening asthma
    Descripción

    history of life threatening asthma

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0004096
    UMLS CUI [1,2]
    C2826244
    respiratory infection or oropharyngeal candidiasis
    Descripción

    respiratory infection or oropharyngeal candidiasis

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0035243
    UMLS CUI [2]
    C0919659
    asthma exacerbation
    Descripción

    asthma exacerbation

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0349790
    uncontrolled disease or clinical abnormality
    Descripción

    comorbidity

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0009488
    allergies
    Descripción

    allergies

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0020517
    taking another investigational medications or other prohibited medications
    Descripción

    another investigational medications or other prohibited medication

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0013230
    UMLS CUI [2,1]
    C0683610
    UMLS CUI [2,2]
    C0013227
    Volver a la parte superior de la página

    Similar models

    Eligibility Asthma NCT00766090

    1 formularios
    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00766090
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    asthma
    Item
    clinical diagnosis of asthma
    boolean
    C0004096 (UMLS CUI [1])
    fev1 reversibility after albuterol
    Item
    reversibility ≥ 12% and ≥200mls reversibility of fev1 within approximately 30-minutes following 2 to 4 puffs of albuterol
    boolean
    C0748133 (UMLS CUI [1,1])
    C0449261 (UMLS CUI [1,2])
    C0001927 (UMLS CUI [2])
    fev1
    Item
    fev1 between 40-85% predicted
    boolean
    C0748133 (UMLS CUI [1])
    short-acting beta-2 agonist
    Item
    currently on short acting beta2 agonist therapy
    boolean
    C1373132 (UMLS CUI [1])
    exclusion criteria
    Item
    key exclusion criteria:
    boolean
    C0680251 (UMLS CUI [1])
    history of life threatening asthma
    Item
    history of life threatening asthma
    boolean
    C0004096 (UMLS CUI [1,1])
    C2826244 (UMLS CUI [1,2])
    respiratory infection or oropharyngeal candidiasis
    Item
    respiratory infection or oropharyngeal candidiasis
    boolean
    C0035243 (UMLS CUI [1])
    C0919659 (UMLS CUI [2])
    asthma exacerbation
    Item
    asthma exacerbation
    boolean
    C0349790 (UMLS CUI [1])
    comorbidity
    Item
    uncontrolled disease or clinical abnormality
    boolean
    C0009488 (UMLS CUI [1])
    allergies
    Item
    allergies
    boolean
    C0020517 (UMLS CUI [1])
    another investigational medications or other prohibited medication
    Item
    taking another investigational medications or other prohibited medications
    boolean
    C0013230 (UMLS CUI [1])
    C0683610 (UMLS CUI [2,1])
    C0013227 (UMLS CUI [2,2])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial